Got my shares and refund. A little selling pressure today it appears. Some overweight retails will flush some out next week. I’m not selling any My valuation for this is just under $2
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress